Pharmala Biotech Holdings, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Feb'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Feb 2026 is 50.00% vs -33.33% in Nov 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Feb 2026 is 25.00% vs 0.00% in Nov 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Feb'26",
        "Nov'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.30",
          "val2": "0.20",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "-0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.30",
          "val2": "-0.40",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,239.60%",
          "val2": "-1,664.60%",
          "chgp": "42.50%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Aug'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Aug 2025 is -40.00% vs 100.00% in Aug 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Aug 2025 is -175.00% vs 0.00% in Aug 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Aug'25",
        "Aug'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.60",
          "val2": "1.00",
          "chgp": "-40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.00",
          "val2": "-0.60",
          "chgp": "-233.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.20",
          "val2": "-0.80",
          "chgp": "-175.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,556.10%",
          "val2": "-643.50%",
          "chgp": "-291.26%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Feb'26 - QoQ

Feb'26

Nov'25

Change(%)

Net Sales

0.30

0.20

50.00%

Operating Profit (PBDIT) excl Other Income

-0.30

-0.30

Interest

0.00

0.00

Exceptional Items

0.00

-0.10

100.00%

Consolidate Net Profit

-0.30

-0.40

25.00%

Operating Profit Margin (Excl OI)

-1,239.60%

-1,664.60%

42.50%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Feb 2026 is 50.00% vs -33.33% in Nov 2025

Consolidated Net Profit

QoQ Growth in quarter ended Feb 2026 is 25.00% vs 0.00% in Nov 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Aug'25

Aug'25

Aug'24

Change(%)

Net Sales

0.60

1.00

-40.00%

Operating Profit (PBDIT) excl Other Income

-2.00

-0.60

-233.33%

Interest

0.00

0.00

Exceptional Items

-0.00

0.00

Consolidate Net Profit

-2.20

-0.80

-175.00%

Operating Profit Margin (Excl OI)

-3,556.10%

-643.50%

-291.26%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Aug 2025 is -40.00% vs 100.00% in Aug 2024

Consolidated Net Profit

YoY Growth in year ended Aug 2025 is -175.00% vs 0.00% in Aug 2024

All Annual Results